Entering text into the input field will update the search result below

Fresenius sees brighter days for pharma division Kabi

Fresenius Headquarter, Bad Homburg

kontrast-fotodesign/iStock Unreleased via Getty Images

German healthcare service provider Fresenius Medical Care (NYSE:FMS) increased its 2023 outlook for its pharmaceutical division Kabi on Thursday, citing demand for clinical nutrition, biosimilars, and plasma products.

Ahead of an investor event, Fresenius (FMS) said that sales at

Recommended For You

Related Stocks

SymbolLast Price% Chg
FMS--
Fresenius Medical Care AG
FSNUF--
Fresenius SE & Co. KGaA